Abstract:Objective: Cellular repressor of E1A-stimulated genes (CREG), a vasculoprotective molecule, is significantly downregulated in atherosclerotic vessels through unclear mechanisms. While epigenetic regulation is involved in atherosclerosis development, it is not known if the CREG gene is epigenetically regulated. The aim of this study was to assess the potential role of CREG methylation in contributing to atherosclerosis. Approach and results: Overexpression of DNA methyltransferase (DNMT)3B significantly inhibited CREG expression in human umbilical vein endothelial cells (HUVECs) and human coronary aortic endothelial cells (HCAECs). Conversely, inhibition of DNA methylation with 5-aza-2'-deoxycytidine (5-aza-dC) dose-dependently increased CREG expression. A CREG promoter analysis identified +168 to +255 bp as a key regulatory region and the CG site at +201/+202 bp as a key methylation site. The transcription factor GR-alpha could bind to the +201/+202 bp CG site promoting CREG transcription, a process significantly inhibited by DNMT3B overexpression. Treatment of cells with oxidized low-density lipoprotein (ox-LDL), a critical atherosclerogenic factor, significantly increased DNMT3B expression, increasing CREG promotor methylation, blocking GR-a binding, and inhibiting CREG expression. Consistently, CG sites in the CREG promoter fragment were hyper-methylated in human atherosclerotic arteries, and CREG expression was significantly reduced. A negative correlation between DNMT3B and CREG expression levels was observed in human atherosclerotic arteries. Finally, Ox-LDL-induced endothelium dysfunction was significantly attenuated by both 5-aza-dC and an anti-oxidative molecular N-acetylcysteine (NAC) administration through rescue the expression of CREG and activation of the p-eNOS/NO pathway. Conclusions: Our study provides the first direct evidence that DNMT3B-mediated CREG gene hypermethylation is a novel mechanism that contributes to endothelial dysfunction and atherosclerosis development. Blocking CREG methylation may represent a novel therapeutic approach to treat ox-LDL-induced atherosclerosis.

Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis.

Homocysteine-Mediated Cholesterol Efflux Via Abca1 and Acat1 Dna Methylation in Thp-1 Monocyte-Derived Foam Cells

DNA Methyltransferase 1 and Krüppel-like Factor 4 Axis Regulates Macrophage Inflammation and Atherosclerosis.

The relationship among ABCA1 DNA methylation and atherosclerosis and blood lipids

Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E–Deficient Mice

Histone demethylase JMJD1C advances macrophage foam cell formation and atherosclerosis progression by promoting the transcription of PCSK9

The Comprehensive Effects of Hyperlipidemia and Hyperhomocysteinemia on Pathogenesis of Atherosclerosis and Dna Hypomethylation in Apoe(-/-) Mice

DNMT1-PPARγ pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice

Knockdown of GAS5 Inhibits Atherosclerosis Progression Via Reducing EZH2-Mediated ABCA1 Transcription in ApoE−/− Mice

DNA Hypermethylation: A Novel Mechanism of CREG Gene Suppression and Atherosclerogenic Endothelial Dysfunction.

High-methionine Diets Accelerate Atherosclerosis by HHcy-mediated FABP4 Gene Demethylation Pathway Via DNMT1 in ApoE(-/-) Mice.

Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE-/- (Apolipoprotein E Deficient) Mice

Reciprocal Regulation Between Mir-148A/152 and DNA Methyltransferase 1 is Associated with Hyperhomocysteinemia-Accelerated Atherosclerosis

Hyperhomocysteinemia in Apoe-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 Via Mir-92a Regulation

Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice

DNA Methylation Aberrant in Atherosclerosis

Dickkopf-1 Promotes Vascular Smooth Muscle Cell Foam Cell Formation and Atherosclerosis Development Through CYP4A11/SREBP2/ABCA1

Eicosapentaenoic Acid Reduces ABCA1 Serine Phosphorylation and Impairs ABCA1-dependent Cholesterol Efflux Through Cyclic AMP/protein Kinase A Signaling Pathway in THP-1 Macrophage-Derived Foam Cells.

Involvement of Histone Methylation in Macrophage Apoptosis and Unstable Plaque Formation in Methionine-Induced Hyperhomocysteinemic Apoe(-/-) Mice

DNA methylation abnormalities in atherosclerosis

Epigenetic control of atherosclerosis via DNA methylation: A new therapeutic target?